EICHORPublic-registry site landscape for NCT05106387, “An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant”, a Chronic Kidney Disease (CKD) study sponsored by Regeneron Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05106387 (registry record) |
| Study title | An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant |
| Official title | A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 With Vonsetamig (BCMA x CD3 Bispecific Antibody) Who Receive a Kidney Transplant |
| Sponsor | Regeneron Pharmaceuticals |
| Condition(s) | Chronic Kidney Disease (CKD) |
| Phase | — |
| Listed sites | 9 |
| Intervention(s) | Noninterventional |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05106387.
Eichor generates a preliminary site-risk snapshot for NCT05106387 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
More from Regeneron Pharmaceuticals
← Eichor home · All tracked trials · Chronic Kidney Disease (CKD) studies · Weekly briefs
